title: Johnson & Johnson pays $181m for misleading marketing of risperidone.
authors.forename: Janice Hopkins
authors.initials: JH
authors.lastname: Tanne
mesh_terms: D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D040541:Marketing / Q000331:legislation & jurisprudence*; D009518:New York; D056687:Off-Label Use / Q000331:legislation & jurisprudence*; D011678:Punishment; D018967:Risperidone / Q000627:therapeutic use
chemical_list: D018967:Risperidone